Welcome to our dedicated page for Zentek SEC filings (Ticker: ZTEK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Zentek Ltd. (ZTEK) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures, primarily furnished on Form 6-K as a foreign private issuer and linked to its Form 40-F and Form F-3 registration statement. These filings supply official documentation that complements Zentek’s press releases on technology, operations and governance.
Recent Form 6-K reports incorporate a range of exhibits, including press releases on Albany Graphite Corp.’s ultra-high purity graphite testing for nuclear and lithium-ion battery applications, the development of a Graphite Gel-Based Fire-Retardant product and related U.S. licensing agreement with Altek Advanced Materials Inc., and updates on ZenGUARD™ Enhanced Air Filters, corporate strategy and international commercialization efforts. Other 6-K filings attach unaudited condensed interim consolidated financial statements, Management’s Discussion and Analysis, and certifications of interim filings by Zentek’s senior officers.
Filings also cover corporate events such as CEO appointments, annual and special meeting voting results, omnibus long-term incentive plan approvals and responses to tax reassessment matters, all documented through exhibits to Form 6-K. For investors tracking Zentek’s advanced materials and healthcare technology activities, these filings provide the formal record of milestones first announced in news releases.
On Stock Titan, users can review these SEC submissions alongside AI-powered summaries that highlight key points from each document, helping to interpret technical content and multi-exhibit reports more efficiently. This includes quick views of technology-related disclosures, governance decisions and financial reporting contained in Zentek’s 6-Ks and other incorporated filings, updated as new documents are furnished to the EDGAR system.
Zentek Ltd. reports that its wholly owned subsidiary Albany Graphite Corp. has engaged independent economic consultancy AppEco Inc. to conduct a comprehensive market research and economic analysis for the Albany graphite project in Northern Ontario. The work covers four areas: an independent price grid by purity grade for nuclear, defense, battery and industrial markets; quantification of addressable demand in North America and allied nations; assessment of Albany’s competitive positioning versus other Western graphite projects, including synthetic substitution risk; and valuation of potential by-product credits from 18 critical minerals recoverable from the fluidized-bed reactor off-gas. Management explains that these independent data are intended to support a preliminary economic evaluation under Instrument national 43-101 and complement engineering work by Micon. Zentek reiterates prior lab results showing Albany graphite achieving 5N+ purity and properties suitable for potential nuclear and battery applications, positioning the project as a potential North American source of critical graphite.
Zentek Ltd., through its subsidiary Albany Graphite Corp., has signed an agreement with American Energy Technologies Co. to supply certified ultra-high-purity graphite samples and process-engineering inputs for the Preliminary Economic Assessment of the Albany Graphite Project being prepared by Micon International.
AETC will produce 4N, 4N+, and 5N+ graphite samples from Albany flotation concentrate with Certificates of Analysis and design a conceptual chlorine-free purification facility targeting 30,000 metric tonnes per year of feedstock. Three independent workstreams—Micon on engineering and economics, AppEco on market pricing, and AETC on process design and certified product—are now active, with key deliverables and the PEA targeted for completion in summer 2026.
Zentek Ltd. reports that its wholly owned subsidiary, Albany Graphite Corp., has engaged AppEco Inc. to complete an independent market research and economic analysis for the Albany Graphite Project in Ontario. The study will develop grade-specific price forecasts, quantify North American and allied-nation demand, analyze Albany’s competitive position, and assess potential value from 18 critical-mineral co-products produced by its electrothermal fluidized bed reactor process.
AppEco’s work is intended to provide independent market data to support a NI 43-101 compliant preliminary economic assessment that engineering firm Micon is preparing. Zentek expects to share workstream findings and anticipates publishing the PEA in the summer.
Zentek Ltd. reported that its subsidiary Triera Biosciences has completed a Government of Canada Innovative Solutions Canada contract focused on an aptamer-based asset to bind and deactivate H5N1 avian influenza. Triera selected a lead aptamer in about seven weeks, highlighting the platform’s speed versus conventional antibody approaches.
On the strength of this work, Triera executed an Ontario Centres of Innovation Collaborate 2 Commercialize agreement to fund development of proprietary seasonal influenza treatment candidates. The OCI C2C project budget is about $300,000, with matched cash contributions from OCI and Zentek, and will target common seasonal influenza A subtypes in collaboration with McMaster University.
Zentek Ltd. reports that its wholly owned subsidiary Albany Graphite Corp. has engaged Micon International to complete a new Preliminary Economic Assessment (PEA) for the Albany Graphite Project in Northern Ontario, with completion expected this summer. The study will incorporate an updated Mineral Resource Estimate and evaluate a thermal purification process that has produced 5N+ graphite at 99.9992 wt.% Cg directly from 86% Cg flotation concentrate using an electrothermal fluidized bed reactor without chlorine.
The PEA will cover mining methods, pit design, production scheduling, process flowsheet, capital and operating cost estimates, environmental and social considerations, and economic and sensitivity analysis under NI 43-101. The current Mineral Resource Estimate, effective April 30, 2023, reports Indicated Mineral Resources of 22.9 million tonnes grading 4.07% graphitic carbon (Cg) and Inferred Mineral Resources of 13.1 million tonnes grading 2.87% Cg, using cut-off grades of 1.22% Cg for open pit and 1.76% Cg for underground resources.
Zentek Ltd. has engaged ICP Securities Inc. to provide automated market-making services using ICP’s proprietary ICP Premium® algorithm, subject to TSX Venture Exchange approval. The agreement starts April 1, 2026, runs for an initial four-month term, and renews monthly unless terminated with 30 days’ notice.
ICP will receive a monthly fee of C$7,500 plus taxes, with no performance-based compensation, stock options, or other securities-related consideration. ICP is an arm’s length party and will bear its own trading costs, aiming primarily to correct temporary supply-demand imbalances and support more orderly, liquid trading in Zentek’s shares.
Zentek Ltd. reports that its wholly owned subsidiary, Triera Biosciences, plans to launch contract research organization services focused on custom aptamer discovery, biosensor enablement, and machine-learning classification for pharma, biotech, and diagnostics clients in Canada, the United States, Europe, and other markets.
Triera’s platform is built on a 20-year exclusive, worldwide, royalty-bearing license with McMaster University covering aptamer applications developed in collaboration with the Li Lab. The business model is client-funded and asset-light, with Triera retaining underlying intellectual property and Zentek expecting these activities may help generate earlier and more predictable revenue to support its broader diagnostics and pharmaceutical initiatives.
Zentek Ltd. reports a favorable court outcome in long‑standing litigation with its former CEO and his consulting firm. The Ontario Superior Court dismissed substantially all claims, which originally exceeded $6 million, including success fee, severance, unpaid wages, defamation, and indemnification demands.
The Court denied a $282,500 success fee claim, $1,350,000 in severance claims, $51,748.82 in alleged unpaid wages, $75,000 in defamation damages, and about $194,000 in indemnification costs. Zentek’s own claim to cancel 4.5 million founder shares and recover related profits was not granted, as the shares were found to be properly issued.
The company’s CEO framed the judgment as closing a difficult chapter and emphasized focusing on core platforms Albany Graphite, ZenGUARD™ and Triera as Zentek continues to develop and commercialize graphene‑enabled and advanced material technologies.
Zentek Ltd. provided an update on its Albany Graphite Project engagement activities around the PDAC 2026 convention in Toronto. The company joined a TSX Canadian Mining Roundtable with senior federal officials to discuss Canada’s critical minerals strategy and highlighted Albany Graphite’s nuclear-grade purity and Northern Ontario location.
Zentek also met separately with federal representatives and Invest Ontario to position Albany within critical minerals funding programs. On the community side, the company participated in Indigenous consultation discussions and held a working session with Constance Lake First Nation, its Indigenous partner, to advance collaboration ahead of environmental baseline studies and a new Preliminary Economic Assessment.
The Albany Graphite deposit, held through Albany Graphite Corp., has achieved 99.9992% ultra-high purity graphite with an equivalent boron concentration of 2.60 ppm in independent bench-scale testing, meeting benchmarks for potential nuclear-grade applications and showing near-theoretical electrochemical performance for lithium-ion battery anodes.
Zentek Ltd. has begun a pilot evaluation program with U.S.-based Quality Filters Inc. to test integrating Zentek’s proprietary air filtration media into Quality’s commercial HVAC and industrial filtration product lines. The program is expected to run for about 8 to 12 weeks and will focus on product compatibility, manufacturing scalability, and performance under real-world commercial conditions.
During this period, the companies will also work on defining the commercial and technical framework for a potential long-term supply arrangement. Zentek views this as an important first step in validating its partnership-led commercialization strategy in the U.S. air filtration market, which industry research estimates could reach about US$7.3 billion by 2032. Zentek also plans to continue assessing U.S. EPA regulatory requirements in parallel with the pilot.